These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 9204961)
21. Downregulation of tazarotene induced gene-2 (TIG2) in skin squamous cell carcinoma. Zheng Y; Luo S; Wang G; Peng Z; Zeng W; Tan S; Xi Y; Fan J Eur J Dermatol; 2008; 18(6):638-41. PubMed ID: 18955196 [TBL] [Abstract][Full Text] [Related]
22. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Schneider SM; Offterdinger M; Huber H; Grunt TW Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091 [TBL] [Abstract][Full Text] [Related]
23. The influence of bexarotene, a selective agonist of the retinoid receptor X (RXR), and tazarotene, a selective agonist of the retinoid acid receptor (RAR), on bone metabolism in rats. Nowak B; Matuszewska A; Filipiak J; Nikodem A; Merwid-Ląd A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A Adv Med Sci; 2016 Mar; 61(1):85-9. PubMed ID: 26569440 [TBL] [Abstract][Full Text] [Related]
25. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. Duvic M; Ni X; Talpur R; Herne K; Schulz C; Sui D; Ward S; Joseph A; Hazarika P J Invest Dermatol; 2003 Oct; 121(4):902-9. PubMed ID: 14632211 [TBL] [Abstract][Full Text] [Related]
26. Specificity of retinoid receptor gene expression in mouse cervical epithelia. Darwiche N; Celli G; De Luca LM Endocrinology; 1994 May; 134(5):2018-25. PubMed ID: 8156902 [TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. DiSepio D; Ghosn C; Eckert RL; Deucher A; Robinson N; Duvic M; Chandraratna RA; Nagpal S Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14811-5. PubMed ID: 9843971 [TBL] [Abstract][Full Text] [Related]
29. Retinoic acid receptor gamma 2 gene expression is up-regulated by retinoic acid in 3T3-L1 preadipocytes. Kamei Y; Kawada T; Kazuki R; Sugimoto E Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):807-12. PubMed ID: 8394693 [TBL] [Abstract][Full Text] [Related]
30. F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling. Rochette-Egly C; Chambon P Histol Histopathol; 2001 Jul; 16(3):909-22. PubMed ID: 11510982 [TBL] [Abstract][Full Text] [Related]
31. Molecular and metabolic retinoid pathways in the human ocular surface. Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666 [TBL] [Abstract][Full Text] [Related]
32. A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation. Yen A; Fenning R; Chandraratna R; Walker P; Varvayanis S Mol Pharmacol; 2004 Dec; 66(6):1727-37. PubMed ID: 15383624 [TBL] [Abstract][Full Text] [Related]
33. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990 [TBL] [Abstract][Full Text] [Related]
34. Pharmacology and molecular action of retinoids and vitamin D in skin. Kang S; Li XY; Voorhees JJ J Investig Dermatol Symp Proc; 1996 Apr; 1(1):15-21. PubMed ID: 9627686 [TBL] [Abstract][Full Text] [Related]
35. Effect of cellular senescence and retinoic acid on the expression of cellular retinoic acid binding proteins in skin fibroblasts. Si SP; Tsou HC; Lee X; Peacocke M Exp Cell Res; 1995 Jul; 219(1):243-8. PubMed ID: 7628539 [TBL] [Abstract][Full Text] [Related]
36. TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Ortiz MA; Piedrafita FJ; Pfahl M; Maki R Mol Endocrinol; 1995 Dec; 9(12):1679-91. PubMed ID: 8614404 [TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells. Huang SL; Shyu RY; Yeh MY; Jiang SY Mol Cell Endocrinol; 2000 Jan; 159(1-2):15-24. PubMed ID: 10687848 [TBL] [Abstract][Full Text] [Related]
38. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands. Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863 [TBL] [Abstract][Full Text] [Related]
39. Current research and future developments in retinoids: oral and topical agents. Chandraratna RA Cutis; 1998 Feb; 61(2 Suppl):40-5. PubMed ID: 9787993 [TBL] [Abstract][Full Text] [Related]
40. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. Pan L; Eckhoff C; Brinckerhoff CE J Cell Biochem; 1995 Apr; 57(4):575-89. PubMed ID: 7615643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]